Stereoselective synthesis of azetidine-derived glutamate and aspartate analogues from chiral azetidin-3-ones

Tetrahedron

Volumn 64, Issue 42, 2008, Pages 9928-9936

  Burtoloso, Antonio Carlos B ^a   Correia, Carlos Roque D ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

(1 TOSYLAZETIDINE 2,3 DIYL)DIMETHANOL; 1 BENZYL 2 (HYDROXYMETHYL)AZETIDINE 3 CARBONITRILE; 1 BENZYL 2 [(TERT BUTYLDIPHENYLSILYLOXY)METHYL]AZETIDINE 3 CARBONITRILE; 2 ((TERT BUTYLDIPHENYLSILYOXY)METHYL) 1 TOSYLAZETIDIN 3 YL)METHANOL; 2 [(TERT BUTYLDIPHENYLSILYOXY)METHY] 3 METHYLENE 1 TOSYLAZETIDINE; 2 PHENYL 1 TOSYL 3 VINYLAZETIDINE; 2 PHENYL 1 TOSYLAZETIDIN 3 ONE; 3 (CARBOXYMETHYL) 1 TOSYLAZETIDINE 2 CARBOXYLIC ACID; 3 (CARBOXYMETHYL)AZETIDINE 2 CARBOXYLIC ACID; 6 TOSYL 3 OXA 6 AZABICYCLO[3.2.0]HEPTAN 2 ONE; ASPARTIC ACID; AZETIDIN 3 ONE DERIVATIVE; AZETIDINE; AZETIDINE 2,3 DICARBOXYLIC ACID; AZETIDINE DERIVATIVE; ETHYL 2 (2 PHENYL 1 TOSYLAZETIDIN 3 YL)ACETATE; ETHYL 2 (2 PHENYL 1 TOSYLAZETIDIN 3 YLIDENE)ACETATE; GLUTAMIC ACID DERIVATIVE; METHYL 3 (2 ETHOXY 2 OXOETHYL) 1 TOSYLAZETIDINE 2 CARBOXYLIC ACID; METHYL 3 [(METHOXYCARBONYL)METHYL] 1 TOSYLAZETIDINE 2 CARBOXYLIC ACID; N (3 DIAZO 2 OXO 1 PHENYLPROPYL) 4 METHYLBENZENESULFONAMIDE; N TOSYL 2 PHENYLGLYCINE; RHODIUM; TERT BUTYL 2 [(TERT BUTYLDIPHENYLSILYOXY) METHYL] 3 HYDROXYAZETIDINE 1 CARBOXYLIC ACID; TERT BUTYL 2 [(TERT BUTYLDIPHENYLSILYOXY)METHYL] 3 (METHYLSULFONYLOXY)AZETIDINE 1 CARBOXYLIC ACID; TERT BUTYL 2 [(TERT BUTYLDIPHENYLSILYOXY)METHYL] 3HYDROXYAZETIDINE 1 CARBOXYLIC ACID; TOLUENE; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CIS ISOMER; DRUG STRUCTURE; EPIMERIZATION; HYDROGENATION; HYDROGENOLYSIS; OLEFINATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; TRANS ISOMER;

EID: 50549094193     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2008.08.001     Document Type: Article

References (56)

1. Kanai Y., Smith C.P., and Hediger M.A. Trends Neurosci. 16 (1993) 365
2. Szatkowski M., and Attwell D. Trends Neurosci. 17 (1994) 359
3. Conn P.J., and Patel J. The Metabotropic Glutamate Receptors (1994), Humana, Totowa/New Jersey, NJ pp 1-277
4. Hollmann M., and Heinemann S. Annu. Rev. Neurosci. 17 (1994) 31
5. Nakanishi S. Neuron 13 (1994) 1031
6. Nicolletti F., Bruno V., Copani A., Casabona G., and Knöpfel T. Trends Neurosci. 19 (1996) 267
7. Daw N.W., Stein P.S., and Fox K.A. Rev. Neurosci. 16 (1993) 207
8. Collingridge G.L., and Bliss T.V.P. Trends Neurosci. 18 (1995) 54
9. Cotman C.W., Kahle J.S., Miller S.E., Ulas J., and Bridges R.J. Excitatory Amino Acid Neurotransmission. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven, New York, NY 75
10. Choi D.W. Annu. Rev. Neurosci. 13 (1990) 171
11. Meldrum B.S. Brain Pathol. 3 (1993) 405
12. Choi D.W. Prog. Brain Res. 100 (1994) 47
13. Rothman S.M., and Olney J.W. Trends Neurosci. 18 (1995) 57
14. Chamberlin A.R., and Bridges R.J. Conformationally Constrained Amino Acids as Probes of Glutamate Receptors and Transporters. In: Kozikowski A.P. (Ed). Drug Design for Neuroscience (1993), Raven, New York, NY 231-259
15. Kozikowski A.P., Tückmantel W., Reynolds I.J., and Wroblewski T.J. J. Med. Chem. 33 (1990) 1561
16. Kozikowski A.P., Tückmantel W., Liao Y., Wroblewski T.J., Wang S., Pshenichkin S., Surin A., and Thomsen C. Bioorg. Med. Chem. Lett. 6 (1996) 2559
17. Kozikowski A.P., Tückmantel W., Liao Y., Wroblewski T.J., Manev H., and Ikonomovic S. J. Med. Chem. 36 (1993) 2706
18. Bridges R.J., Lovering F.E., Humphrey J.M., Stanley M.S., Blakely T.N., Cristofaro M.F., and Chamberlin R. Bioorg. Med. Chem. Lett. 3 (1993) 115
19. Arakawa Y., Murakami T., Arakawa Y., and Yoshifugi S. Chem. Pharm. Bull. 51 (2003) 96
20. De Kimpe N., and Boeykens M. Tetrahedron 54 (1998) 2619
21. Hanessian S., Bernstein N., Yang R., and Maguire R. Bioorg. Med. Chem. Lett. 9 (1999) 1437
22. Couty F., Evano G., and Rabasso N. Tetrahedron: Asymmetry 14 (2003) 2407
23. Couty F., Carlin-Sinclair A., and Rabasso N. Synlett (2003) 726
24. Enders D., and Gries J. Synthesis-Stuttgart 20 (2005) 3508
25. Kiss L., Mangelinckx S., Fülöp F., and DeKimpe N. Org. Lett. 9 (2007) 4399
26. Sivaprakasham M., Couty F., Evano G., Srinivas B., Sridhar R., and Rao K.R. Arkivoc 10 (2007) 71
27. Gerona-Navarro G., Angeles Bonache M., Alías M., Pérez de Vega M.J., García-López T., Pilar López M., Cativiela C., and González-Muñiz R. Tetrahedron Lett. 45 (2004) 2193
28. Braüner-Osborne H., Bunch L., Chopin N., Couty F., Evano G., Jensen A.A., Kusk M., Nielsen B., and Rabasso N. Org. Biomol. Chem. 3 (2005) 3926
29. Couty F., and Evano G. Org. Prep. Proced. Int. (2006) 427
30. Burtoloso A.C.B., and Correia C.R.D. Synlett (2005) 1559
31. Burtoloso A.C.B., and Correia C.R.D. Tetrahedron Lett. 45 (2004) 3355
32. Burtoloso A.C.B., and Correia C.R.D. J. Organomet. Chem. 690 (2005) 5636
33. For a review on azetidin-3-ones, see:. Dejaegher Y., Kuz'nenok N.M., Zvonok A.M., and De Kimpe N. Chem. Rev. 102 (2002) 29
34. Compound 4 was also prepared by Pusino:. Pusino A., Saba A., and Desole G. Gazz. Chim. Ital. 115 (1985) 33
35. 2, see:. Wang J., Hou Y., and Wu P. J. Chem. Soc., Perkin Trans. 1 (1999) 2277
36. For previous applications of the Wittig olefination of azetidin-3-ones, see:
37. Hanessian S., Fu J., Chiara J.L., and Di Fabio R. Tetrahedron Lett. 34 (1993) 4157
38. Podlech J., and Seebach D. Helv. Chim. Acta 78 (1995) 1238
39. Emmer G. Tetrahedron 48 (1992) 7165
40. Liu H., and Ramani B. Synth. Commun. 15 (1985) 965
41. The cis compound 6 could not be separated from its trans isomer by column chromatography.
42. Matsuura F., Hamada Y., and Shioiri T. Tetrahedron Lett. 33 (1992) 7921
43. The use of diazomethane was merely to facilitate isolation and purification of 9. Compound 9 was obtained as an inseparable mixture of the cis and trans stereoisomers.
44. Clayden J., Menet C.J., and Tchabanenko K. Tetrahedron 58 (2002) 4727
45. Bergmeier S.C., and Seth P.P. Tetrahedron Lett. 40 (1999) 6181
46. Closson W.D., Ji S., and Schulenberg S. J. Am. Chem. Soc. 92 (1970) 650
47. In some occasions, a small amount of epimerization at C2 was observed.
48. Attempts to carry out this epimerization step beyond the cis/trans ratio of 20:80 were fruitless. As a typical procedure, 0.10 mmol of compound 12 is dissolved in 3.0 mL of dry toluene. After that, 10 equiv of pure DBU is added and the solution stirred under reflux for 7 h. After cooling, the solution is filtered in a short pad of silica and the silica washed with 30% EtOAc/hexanes. The organic layers are combined and evaporated to yield the epimerized trans diester in 60% yield as a inseparable mixture of isomers (8:2 trans:cis).
49. Petasis N., and Bzowej E.I. J. Am. Chem. Soc. 112 (1990) 6392
50. Hanessian S., and Fu J. Can. J. Chem. 79 (2001) 1812
51. Masuda K., Okutani T., and Kaneko T. Chem. Pharm. Bull. 22 (1974) 1490
52. Masuda K., and Okutani T. Chem. Pharm. Bull. 22 (1974) 1498
53. Marchand A.P., and Bartnik R. Synlett (1997) 1029
54. Conditions employed different protocols for Jones oxidation and IBX oxidation to the aldehyde, followed by Pinick oxidation.
55. Jiang J., Shah H., and Devita R.J. Org. Lett. 5 (2003) 4101
56. Frank Lovering Ph.D. Thesis (www.umi.com/proquest), under the supervision of Richard Chamberlin (University of California, Irvine).